Historically, the renal entity of chronic atrophic pyelonephritis emerged from a series of clinical and pathological observations beginning with those of Wagner in 1882 (1) and extending to those of Weiss and Parker in 1939 (2) . Most of the cases reported were in children and young adults who had a history of recurrent urinary tract infection dating back to early childhood. However, in some of these cases there was no such history of urinary infection. The same observations are also true today. The genesis of the renal scarring typical of chronic atrophic pyelonephritis has been a matter of controversy for at least three decades. For many years most of us were convinced (and some may still be) that recurrent bacterial infection of the kidney is primarily responsible for the pathologic entity of chronic pyelonephritis. Pathologically, the term "chronic pyelonephritis" describes shrunken, irregular, coarsely scarred kidneys with focal thinning of the renal parenchyma, often from an original thickness of 3 centimeters to a final depth of only 2 millimeters (3). However, after almost three decades of following up patients, primarily women, with recurrent urinary tract infections, we have learned that recurrent bacteriuria alone, i.e. in the absence of some form of obstructive uropathy, rarely, if ever, leads to chronic renal failure and to the pathologic entity of chronic atrophic pyelonephritis (4, 5) . Many etiologic agents have been shown to produce chronic tubulointerstitial damage, but only a limited number of conditions lead to the pathologic picture of chronic pyelonephritis (3, 6) . These are: a) vesicoureteral reflux (7); b) urinary obstruction (6); c) analgesic nephropathy; d) unusual forms of papillary necrosis which occur in association with sickle cell disease, focal tuberculosis, or severe dehydration in infants (8); and e) segmental hypoplasia (the Ask-Upmark kidney) (3, 6, 9) . We now know that in the vast majority of patients with typical pyelonephritic scarring following bacterial infection, there is an underlying anatomic urinary tract anamoly, urinary obstruction or most commonly vesicoureteral reflux. The close association between chronic pyelonephritis and vesicoureteral reflux was first established in 1960 by Hodson and Edwards (7), and has since been confirmed by many other observers. Vesicoureteral reflux is frequently present (about 50%) in adults with classic pyelonephritic scarring and is almost always present (more than 90 %) in children with this renal pathology (10). Furthermore, in a significant proportion of cases, vesicoureteral reflux associated scarring will ultimately progress to end-stage renal disease requiring dialysis or transplantation (3, 6, 11) . In some centers 15 to 20% of adults under 50 years of age, and more than 30 % of children requiring renal substitution have this diagnosis (3, 6) . These observations led to the introduction of the term "reflux nephropathy", which has now replaced the term "chronic pyelonephritis", for referring to reflux associated renal scarring (12). The question still remains as to what the relationship is between reflux, infection and renal scarring. Reflux nephropathy in the absence of urinary tract infection has been observed to progress to severe (end-stage) renal scarring in children (13) and in experimental animal models of reflux (14, 15). Of those patients with renal failure resulting from reflux nephropathy, only 60% have a history of urinary tract infection (3). This observation -that the renal scarring associated with reflux nephropathy can occur in the absence of infection -has led to much of the controversy about the pathogenesis of these lesions. Although there is a history of recurrent urinary tract infection in most children with this disease, others present early in adult life with gross reflux, severe renal damage and no history of urinary tract infection (3) . Vesicoureteral reflux is present in 30 to 50% of children with recurrent urinary tract infection and is the most common abnormality associated with infection regardless of whether the disease is symptomatic or asymptomatic (16). It is present in more than 90% of children with pyelonephritic scarring, but not all children with vesicoureteral reflux (only 30 to 60 %) go on to develop renal scars (10, 16). These findings do not explain the mechanism by which vesicoureteral reflux injures the kidney. Clinical and experimental evidence has shown that vesicoureteral reflux can produce intrarenal reflux of urine and that this correlates with pyelonephritic scarring, lntrarenal reflux was observed in patients, mostly children less than five years of age, who had more severe grades of vesicoureteral reflux (17) . A direct relationship was observed between age and the pressure required to produce intrarenal reflux in the human kidney, i.e. lower pressures are required to produce intrarenal reflux in kidneys of younger children (6) correlating with the increased susceptibility of younger children to pyelonephritic scarring. Intrarenal reflux was shown to occur predominantly in compound papillae both in children and pigs (18, 19) . The location of these compound papillae in the renal poles correlates with the polar distribution of pyelonephritic scars. Normal urinary proteins, particularly Tamm-Horsfall protein (THP), can be detected in the renal interstitium, renal veins and lymphatics, and peri-renal lymph nodes in association with intrarenal reflux (20, 21) . This later observation led to the suggestion of an immunopathogenic mechanism of renal scarring in vesicoureteral reflux or in other acquired states which produce retrograde urine flow. An immunopathologic response to such an antigen would help explain why the histologic lesions of reflux nephropathy, chronic pyelonephritis or chronic tubulointerstitial nephritis are characterized by mononuclear cellular infiltrates and fibrosis rather than polymorphonuclear leukocytes. Several clinical and experimental observations support a relationship between THP and the development of pYelonephritic scarring in association with reflux. TI-IP is synthesized in the tubular epithelial cells of the thick ascending limb of the loop of Henle and the distal convoluted tubules, where under normal conditions it adheres to the luminal surface (22) . THP is secreted into the urine in quantities of approximately 25/~g/ml and has not been conclusively demonstrated elsewhere in the body. Its exact physiologic function is unknown, although it may influence the water permeability characteristics of the loop of Henle and, conceivably, might protect urinary tract mucosa from the effects of bacteria or viruses (23) . Interstitial deposits of THP have been detected in approximately 50% of patients with medullary cystic disease, approximately 30 % of 100 human kidneys from patients with chronic pyelonephritis, reflux nephropathy or obstructive uropathy as compared with less than 2 % of patients with glomerulonephritis (20) . Although these THP deposits appear to have come from adjacent ruptured tubules, the amorphous THP is frequently surrounded by focal mononuclear cell infiltrates. Also, acute ureteral obstruction in mice, rats, and swine produces extravasated interstitial deposits of THP within one to two hours (24) . Serologic responses (IgG) to human THP have been observed in patients with recent urinary obstruction, vesicoureteral reflux, and acute pyelonephritis, but not in patients with cystitis, asymptomatic bacteriuria, reflux nephropathy with scarring, or end-stage renal disease (25) . The following studies from our laboratory were designed to investigate further the immunopathogenic role of THP in a rabbit model of tubulointerstitial nephritis, and in a swine model of reflux nephropathy. Rabbits were challenged i.v. with one of the following sterile solutions: (1) homologous rabbit urine containing rabbit THP; (2) rabbit urine selectively depleted of THP; (3) autologous rabbit urine containing THP and obtained by bladder catheterization; and (4) purified rabbit THP. Unchallenged, agematched rabbits were used as normal controls. Light microscopy of kidney sections demonstrated a characteristic focal tubulointerstitial nephritis at the corticomedullary junction in 9 % of rabbits challenged with homologous urine after two to 12 weeks, and in 83 % after 16 to 48 weeks of challenge (26) . The same lesions were observed in 78% of rabbits challenged with autologous urine and 79% challenged with purified rabbit THP. In comparison, none of the unchallenged controls and 7 % (one rabbit) of those challenged with THP-depleted homologous urine developed tubulointerstitial nephritis. Tubulointerstitial nephritis developed more rapidly in rabbits challenged with purified rabbit THP than in rabbits challenged with homologous urine. Early lesions consisted of focal mononuclear cell infiltrates that encircled isolated tubular segments identified as thick ascending limbs of the loop of Henle. Later lesions were more severe, contained more fibroblasts and collagen, had more tubular atrophy and often extended in a radial manner within medullary rays.
Immunofluorescence studies failed to demonstrate significant immunoglobulin deposition in any of the challenged animals. Electron microscopy studies demonstrated mononuclear cells along the thick ascending limb of the loop of Henle and fibrosis. Serum anti-THP antibody elevations (IgG) were common in rabbits challenged with either rabbit urine containing THP or rabbit THP and correlated with the finding of tubulointerstitial nephritis. Cellmediated immune responses to THP were observed in approximately one-half the rabbits challenged with either urine containing THP or purified THP. In contrast, only three of 35 rabbits in the two control groups (unchallenged and THP-depleted urine) had cytotoxic lymphocytes. The presence of cytotoxic lymphocytes correlated with the development of tubulointerstitial nephritis. These studies suggested that rabbit THP is the major antigen in urine to which lymphocytes are sensitized; that the effector cells are functional T-lymphocytes since they are non-adherent to nylon wool columns; and that the soluble supernatant (lymphokine) of the interaction between antigen and effector lymphocyte is responsible for cytotoxicity. In the porcine model of reflux nephropathy 21 female miniature pigs underwent cystotomy and right ureteral orifice meatotomy with placement of a nonconstricting 3 or 4 mm omega-shaped ring around the proximal urethra. The kinetics of the pyelographic changes in porcine reflux nephropathy indicate that bladder dilatation occurred after approximately one month, ureteral dilatation after 39 days, renal insufficiency after 57 days and renal scarring after 71 days (25) . Serum anti-THP antibody titer elevations developed in association with ureteral dilatation. Serum titers decreased in association with removal of the urethral omega ring, which was required to reverse P.M. Miniter et al.
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severe uremia. Pyelographic evidence of coarse focal scarring occurred in 15 of 21 animals at this time. Lymphocyte-mediated cytotoxicity was studied in pigs preoperatively and when intravenous pyelography demonstrated bladder dilatation only, ureteral dilatation, and hydronephrosis with uremia. Abnormal lymphocyte cytotoxicity was seen most frequently when pigs developed ureteral dilatation. Histopathologic examination of the kidneys demonstrated chronic tubulointerstitial nephritis characterized by mononuclear cellular infiltrates often associated with interstitial THP deposits, and large focal scars. The observations that lymphocyte-mediated cytotoxicity develops (in challenged rabbits and refluxing pigs) against susceptible target fibroblasts in the presence of THP, suggests that ceil-mediated immunity to Tamm-Horsfall protein plays an important role in the pathogenesis of tubulointerstitial nephritis. Earlier animal models of tubulointerstitial nephritis by Neilson and Phillips (27) also suggest that cellmediated immunity to renal tubular antigens plays an important role in the pathogenesis of renal damage and fibrogenesis and that the elaboration of soluble factors by sensitized lymphocytes is a primary mechanism of renal damage. The immune response to THP was studied also in patients with nephrolithiasis. Serum IgG anti-human THP antibody and peripheral lymphocyte-mediated cytotoxicity and lymphocyte transformation in the presence of human THP were determined in 49 patients attending the Yale-New Haven Hospital Renal Stone Clinic who provided informed consent for a venipuncture. All patients (32 men and 17 women) had recurrent nephrolithiasis. Twelve of the 49 showed elevated antibody titers to human THP as compared with none of 12 normal control subjects. Those patients with elevated antibody titers, as compared with those with normal antibody titers, had the first stone develop more recently, and also had another more recent stone event (50% versus 11%, p<0.02). Cell-mediated immunity to THP was studied in 24 patients of whom 13 were slightly more responsive than the normal panel in either the lymphocyte transformation assay or the lymphocyte mediated cytotoxicity test, but not in both (25) . Bacterial infection if not a cause of chronic pyelonephritis certainly appears to be a risk factor (28) . The theory that antigenic similarities between Escherichia coli and THP existed and could contribute to the immunopathology of chronic pyelonephritis was first advanced by Fasth et al. (29) . We further investigated possible cross-reactivity between uropathic cotiforms and human THP using a competition radioimmunoassay (25) We were able to demonstrate that the veronal extracts bound to solid phase THP. The binding was directly proportional to both the concentration of THP used to coat the solid phase and the concentration of the veronal extract itself. The bacterial extracts were further found to inhibit an unrelated system -the binding of Aspergillus fumigatus to its antibody. These findings suggest that the cross-reactivity seen in the immunoassays is caused by the interaction between the protein extracts of uropathic coliforms and THP, and is not representative of true immunologic cross-reactions for a common antigen. These results do not exclude the possibility that bacterial infection may enhance an autoimmune response to THP by other mechanisms. For example, the initial renal damage seen with bacterial infection may liberate THP into the systemic circulation and allow an induction of autoimmunity which can cause renal damage after the infection has resolved. Alternatively, bacterial products may in some way act as an adjuvant. A combination of tissue destruction, exposure to THP and an adjuvant effect could create an enhanced immune response to THP. In summary, evidence has been presented that vesicoureteral reflux can lead to renal injury and scarring in the absence of infection, and that autoimmune responses to Tamm-Horsfall protein may occur after exposure to Tamm-Horsfall protein by intravenous challenge, urinary reflux, or recurrent nephrolithiasis. This autoimmune response to Tamm-Horsfall protein may be the pathogenetic mechanism by which these factors and bacteriuria contribute to the development of the pathologic lesion we call chronic pyelonephritis. 
